Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Transplantation and Cellular Therapy|January 19, 2024
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation RecipientsAnthony D Sung, Thuy Koll, Shannon H Gier, et al.Leukemia|January 5, 2024
FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemiaPamela J Sung, Murugan Selvam, Simone S Riedel, et al.Plos One|October 26, 2020
Targeted detection and quantitation of histone modifications from 1,000 cellsNebiyu A Abshiru, Jacek W Sikora, Jeannie M Camarillo, et al.The New England Journal of Medicine|October 31, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AMLAlexander E Perl, Giovanni Martinelli, Jorge E Cortes, et al.Cancer Discovery|January 27, 2021
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML RecurrenceCihangir Duy, Meng Li, Matt Teater, et al.European Journal of Haematology|December 27, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based RegimenMargaret Rowe, Daria Babushok, Martin Carroll, et al.JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.Nature Medicine|September 19, 2017
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsLy P Vu, Brian F Pickering, Yuanming Cheng, et al.Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.Leukemia|March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibitionV S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.Pageof 19